Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 2391-2400 Newer>

Managed Care September 2005 John Carroll	DM Industry Confident It Can Hit Medicare Goals Though there are challenges to serving the elderly, the movers and shakers of disease management say that they should be able to cut costs in pilot populations by 5%.
Managed Care September 2005	Biologics Trend Leads Pharmaceuticals The general stabilization in per-capita medical claims cost -- what services cost the health plan before the member is charged -- for the managed care industry has not, for the most part, spilled over to biologics, according to a survey.
The Motley Fool October 5, 2005 Stephen D. Simpson	Lupus Trials Spook Investors Lupus is a high-risk, high-reward indication, and today's disappointing trial results aren't the end of the story for Human Genome Sciences. Aggressive and experienced investors might want to take a look at this one, but this is clearly not a stock for the faint of heart.
The Motley Fool October 5, 2005 Stephen D. Simpson	Wright Goes Wrong A weak third quarter compounds troubles for this pipeline-challenged orthopedics player. There is no compelling reason to purchase this stock today.
The Motley Fool October 4, 2005 Jack Uldrich	Innovation From Down Under Two Australian nanotech companies look to grow and lead the way in disease prevention. At the same time, though, remember that both Starpharma and pSivida are speculative small-cap stocks and, as such, carry big risks, including a predisposition to volatility.
BusinessWeek October 10, 2005 Howard Gleckman	Medicare's Big Experiment The coming changes to Medicare aim to cut costs while improving care. Sound familiar?
BusinessWeek October 10, 2005 Howard Gleckman	Why MDs Are IT-Phobic Information technology promises savings for patients and health-care companies, but going electronic can be a bitter pill for the MDs footing the bill.
Home Toys October 2005 Ofer Atzmon	Innovative Mobile-Health Solutions May be Integrated with Smart Homes Future advances in wireless technologies, such as WiMax will enable the integration of wireless healthcare services inside the smart home environment, freeing users from the need to frequent their doctors.
The Motley Fool September 30, 2005 Stephen D. Simpson	Two Pharma Trees Fall The news of a phase 3 trial failure hammers both Forest Labs and Cypress Bioscience. Investors, take note.
The Motley Fool September 28, 2005 Stephen D. Simpson	Affymetrix Stumbles Again Though the company was one of the only genomics plays to escape the bubble with a real business and a solid market cap, Affymetrix's stock seemed poised to take a serious hit Wednesday for the second time in about three months.
<Older 2391-2400 Newer> Return to current articles.